You position:
Home
/
/
Pluslife in Sao Paulo,Hospitalar 2022

Pluslife in Sao Paulo,Hospitalar 2022

  • Categories:News & Events
  • Author:Tanjo
  • Origin:
  • Time of issue:2022-05-26 15:41
  • Views:

(Summary description) Hospitalar 2022 discloses the importance of uniting basic knowledge with innovative and disruptive technology. In addition to deepening and expanding essential industry knowledge, connecting solutions and products, reviewing processes and delivering even greater patient care. Therefore, learning needs to be continuous and, whenever possible, health specialists need to go back to the “basic”, that is, to provide care in a more humanized and less formal way, without giving up the technological innovation available on a daily basis. As on-site Protable POCT system developer and manufacturer, Pluslife applys self -developed isothermal molecular detection technology---the Pluslife RHAM, the Mini Dock  PM001 ables to provide accurate test results that are comparable to top laboratory PCR tests, while it is easier to move around and adopt to many situations. Combining convenience and reliabilities, Mini Dock PM001 provides good potencial of point-of -care nucleic acid tests that detects Covid-19, STD and Influenza.

Pluslife in Sao Paulo,Hospitalar 2022

(Summary description)
Hospitalar 2022 discloses the importance of uniting basic knowledge with innovative and disruptive technology. In addition to deepening and expanding essential industry knowledge, connecting solutions and products, reviewing processes and delivering even greater patient care.

Therefore, learning needs to be continuous and, whenever possible, health specialists need to go back to the “basic”, that is, to provide care in a more humanized and less formal way, without giving up the technological innovation available on a daily basis.

As on-site Protable POCT system developer and manufacturer, Pluslife applys self -developed isothermal molecular detection technology---the Pluslife RHAM, the Mini Dock  PM001 ables to provide accurate test results that are comparable to top laboratory PCR tests, while it is easier to move around and adopt to many situations. Combining convenience and reliabilities, Mini Dock PM001 provides good potencial of point-of -care nucleic acid tests that detects Covid-19, STD and Influenza.

  • Categories:News & Events
  • Author:Tanjo
  • Origin:
  • Time of issue:2022-05-26 15:41
  • Views:
Information


Hospitalar 2022 discloses the importance of uniting basic knowledge with innovative and disruptive technology. In addition to deepening and expanding essential industry knowledge, connecting solutions and products, reviewing processes and delivering even greater patient care.

Therefore, learning needs to be continuous and, whenever possible, health specialists need to go back to the “basic”, that is, to provide care in a more humanized and less formal way, without giving up the technological innovation available on a daily basis.

As on-site Protable POCT system developer and manufacturer, Pluslife applys self -developed isothermal molecular detection technology---the Pluslife RHAM, the Mini Dock  PM001 ables to provide accurate test results that are comparable to top laboratory PCR tests, while it is easier to move around and adopt to many situations. Combining convenience and reliabilities, Mini Dock PM001 provides good potencial of point-of -care nucleic acid tests that detects Covid-19, STD and Influenza.

Keyword:

Related News

There is currently no information to display
Please add data record on website background.

Tel: +86-2031607074
E-mail: market@pluslife.com

Add: 3F-Block E, Runhui Science & Technology Park, No. 18 Shenzhou RD, Huangpu District, Guangzhou, Guangdong, China

PLUSLIFE BIOTECH

Monday - Friday, 08:00 -20:00

Copyright © 2021 Guangzhou Pluslife Biotech Co., Ltd.  粤ICP备19038432号  Powered by www.300.cn